PUBLICATIONS - 1994-1995 FDA Directory available in hard copy or computer disk:
This article was originally published in Clinica
The 1994-1995 FDA Directory is now available in hard copy or on computer disk. It offers a complete listing of all FDA offices, centres and field organisations and personnel. Further details are available from: The Food & Drug Law Institute, Educational Resources Dept, 79304 Baltimore, MD 21279-0304, US. Tel: +1 (202) 371 1420. Fax: +1 (202) 371 0649.
You may also be interested in...
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.